AIM ImmunoTech
32 hedge funds and large institutions have $5.88M invested in AIM ImmunoTech in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 5 closing their positions.
900% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
45% more funds holding
Funds holding: 22 → 32 (+10)
27% more capital invested
Capital invested by funds: $4.64M → $5.88M (+$1.24M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$823K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$292K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$239K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$167K |
| 5 |
BCM
Bayesian Capital Management
Brooklyn,
New York
|
+$105K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$92.4K |
| 2 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
-$72K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$63K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$44K |
| 5 |
MFG
Magnus Financial Group
New York
|
-$35K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SFI
26
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $25K | – | – | – |
|
|
ASN
27
Advisory Services Network
Atlanta,
Georgia
| $3K | +$3.25K | +13 | New |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
APA
29
American Portfolios Advisors
Holbrook,
New York
| $490 | – | – | – |
|
30
Millennium Management
New York
| $38 | +$44.2K | +177 | New |
|
|
SAMH
31
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
| – | -$72K | -290 | Closed |
|
|
32
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$63K | -253 | Closed |
|
|
CS
33
Credit Suisse
Zurich,
Switzerland
| – | -$44K | -177 | Closed |
|
|
MFG
34
Magnus Financial Group
New York
| – | -$35K | -140 | Closed |
|
|
SLG
35
Stanley-Laman Group
Berwyn,
Pennsylvania
| – | -$32K | -130 | Closed |
|
AIM Hedge Fund Activity: Q3 2020 in Review
32 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2020, worth a combined $5.88M — up 27% from $4.64M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new AIM positions and 5 closed out — a net gain of 10 holders — while 10 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $823K. The largest seller was Virtu Financial, cutting an estimated $92.4K.
- 32 institutional investors held AIM ImmunoTech (AIM) as of Q3 2020, up from 22 in Q2 2020.
- Funds reported $5.88M of AIM ImmunoTech stock for Q3 2020, up 27% quarter-over-quarter.
- 15 funds opened new AIM ImmunoTech positions in Q3 2020 and 5 closed out, a net change of +10 holders.
- The largest AIM ImmunoTech buyer in Q3 2020 was Morgan Stanley, an estimated $823K added.
- The largest AIM ImmunoTech seller in Q3 2020 was Virtu Financial, an estimated $92.4K sold.
Based on aggregated 13F filings for Q3 2020.